Cramer's lightning round: Buy Regeneron, it's not getting the credit it deserves
December 14, 2017 at 18:46 PM EST
Jim Cramer zoomed through his take on callers' favorite stocks, including a pharma play.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|